This inhibition was also partly dependent on type I IFN, in line with the reported exacerbation of GVHD in IFNAR‐1−/− B6 recipients of BALB/c CD4 T cells and by the inhibition of allogeneic donor T cell responses by IFNα 42. This evidence concerns the gene IFNAR1 and graft versus host disease.